Skip to main content

Healthcare Finance Staff

By Healthcare Finance Staff | 04:28 pm | May 30, 2017
Healthcare IT News and HIMSS are accepting speaking proposals for the Big Data and Healthcare Analytics Forum to be held in Boston, October 23-24.
By Healthcare Finance Staff | 12:45 pm | December 28, 2016
While the majority of our picks explored the shockwaves caused by the presidential election, Zika virus and gun policy also made appearances.
By Healthcare Finance Staff | 02:32 pm | December 27, 2016
Emergency rooms grappling with an overburdened mental health system tops list, followed by the importance of measuring population health.
By Healthcare Finance Staff | 09:08 am | November 11, 2016
The president-elect's policies will have immediate impact on U.S. hospitals, ambulatory centers, health insurers and supply chain companies.
By Healthcare Finance Staff | 10:00 am | September 27, 2016
Tran has led finance teams for several top-ranked health plans.
By Healthcare Finance Staff | 11:57 am | August 04, 2016
The clock is ticking and the agenda is filling for the Dec. 6-7 HIMSS and Healthcare Finance News Revenue Cycle Solutions Summit in Boston. Topic and speaker proposals are being accepted until next Friday, August 12.
By Healthcare Finance Staff | 02:47 pm | June 02, 2016
Healthcare IT News and HIMSS are accepting topic and speaker proposals for Pop Health Forum 2016 scheduled for September 12-13 in Chicago.
By Healthcare Finance Staff | 08:37 pm | March 02, 2016
LAS VEGAS – Officials from the Centers for Medicare and Medicaid Services on Wednesday said physicians should expect meaningful use of electronic health records to still be required under coming changes to how CMS pays them under MACRA.
By Healthcare Finance Staff | 01:46 pm | March 02, 2016
LAS VEGAS -- When Inova Health saw that Affordable Care Act initiatives for value-based care would cut 7 percent, or $220 million, out of the $3 billion health system's successful fee-for-service revenues, the northern Virginia provider knew it needed to change, said President and COO Mark Stauder.
By Healthcare Finance Staff | 03:35 pm | March 01, 2016
MIT Sloan Professor Andrew Lo, Dana-Farber Cancer Institute's David Weinstock, and MIT post-doctoral fellow Vahid Montazerhodjat have identified this as a time when breakthrough therapies for certain types of cancers, hepatitis C, and rare diseases exist but remain out of reach for many patients, due primarily to the prohibitive cost.